Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | 0.00% | +24.00% | -15.76% |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Biodesix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 66.17M | Sales 2025 * | 80.4M | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -31M | EV / Sales 2024 * | 2.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 * |
-4.27
x | P/E ratio 2025 * |
-5.6
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.47% |
Latest transcript on Biodesix, Inc.
1 week | +24.00% | ||
Current month | +25.00% | ||
1 month | +9.93% | ||
3 months | -22.11% | ||
6 months | +16.54% | ||
Current year | -15.76% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.55 | 0.00% | 73,004 |
24-05-07 | 1.55 | +1.97% | 204,914 |
24-05-06 | 1.52 | +8.57% | 236,823 |
24-05-03 | 1.4 | +6.87% | 151,010 |
24-05-02 | 1.31 | +4.80% | 60,321 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.76% | 176M | |
-17.08% | 8.39B | |
+45.61% | 3.74B | |
-36.69% | 2.55B | |
-8.41% | 2.48B | |
-13.14% | 2.32B | |
-6.49% | 1.93B | |
-17.24% | 1.6B | |
-37.21% | 1.28B | |
+5.14% | 1.08B |
- Stock Market
- Equities
- BDSX Stock